Skip to main content

Advertisement

Fig. 4 | Parasites & Vectors

Fig. 4

From: Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

Fig. 4

Serum-specific IgG, IgG1 and IgG2a antibody levels by ELISA 8 weeks post-challenge against soluble adult worm antigens from S. mansoni (SoSbAWA). Data presented as the mean ± standard error of the mean. BALB/c mice were vaccinated with their respective antigens formulated with the adjuvant adaptation (ADAD) vaccination system with the natural immunomodulator PAL or the synthetic AA0029 and challenged with 150 cercariae of S. mansoni. a Vaccination with PAL+Qs+nFh12+PAL; b Vaccination with PAL+Qs+rFh15; c vaccination using AA0029+Qs+rFh15 and AA0029+Qs+rFh15b. O.D., optical densities; *P < 0.05 compared to uninfected controls

Back to article page